Objective: To compare left carotid intima-media thickness (CIMT) and biochemical markers for atherogenesis in neonatal venoarterial extracorporeal membrane oxygenation (ECMO) survivors with normal controls during childhood.
Introduction
Extracorporeal membrane oxygenation (ECMO) is used to treat severe cardiorespiratory failure refractory to conventional medical management. In newborns, ECMO is most commonly used to treat respiratory failure caused by meconium aspiration syndrome, congenital diaphragmatic hernia, sepsis/pneumonia and persistent pulmonary hypertension. Since the inception of ECMO support, the Extracorporeal Life Support Organization (ELSO) registry has documented over 14 000 late preterm and term neonates treated with venoarterial ECMO for respiratory indications, resulting in an overall survival of 73% 1 The most common approach to providing ECMO support in neonates is achieved by cannulation of the right common carotid artery (RCCA) and the right internal jugular vein. Most ECMO centers ligate the RCCA at the time of ECMO decannulation. Although no adverse effects are clinically apparent following ECMO support and ligation of the RCCA, these children are dependent on only three arteries (the vertebral arteries and the left carotid artery) to maintain adequate cerebral perfusion. As many of these former neonatal venoarterial ECMO survivors are reaching young adulthood, we set out to investigate whether neonatal ECMO survivors are at an increased risk for premature atherosclerosis and cardiovascular disease (CVD). In adults and older children, carotid artery intima-media thickness (CIMT) is an accepted marker for CVD risks. 2 Indeed, in adult populations, when elevated, CIMT is associated with an increased risk for peripheral arterial disease, stroke and coronary events. [3] [4] [5] [6] The objective of our study was to compare CIMT and biochemical markers for atherogenesis in neonatal ECMO survivors who had their RCCA ligated to normal controls at 12 to 18 years of age.
Methods

Study population
In this matched control prospective study, survivors of neonatal venoarterial ECMO performed at Childrens Hospital Los Angeles who have been followed in the high-risk neonatal follow-up clinic and were between 12 and 25 years of age at the time of enrollment, were eligible. Normal patients (controls) were chosen from earlier participants of a research study at Childrens Hospital Los Angeles who had undergone bone density measurement studies using computed tomography and had biochemical determinations of serum markers done between 12 and 25 years of age. Exclusion criteria for the selection of controls included teenagers no longer within the 5th and 95th percentiles for height and weight according to the mean age-adjusted normal values for children, 7 patients diagnosed with a major illness, or those taking medications known to influence body composition, insulin action or insulin secretion. All patients and their adult guardians provided written informed consent. The study was reviewed and approved by the Childrens Hospital Los Angeles Institutional Review Board.
Study protocol
Potential candidates for enrollment in this study were mailed letters of invitation to participate in this research study with an indication of our intent to contact them through telephone. In patients that expressed an interest in participating, noninvasive blood pressure and height and weight measurements were obtained, and BMI was calculated. 7 Fasting status was determined by self-report and laboratory studies included serum insulin, glucose, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, homocysteine and highsensitivity C-reactive protein.
Homocysteine was measured using a modified highperformance liquid chromatography method 8 and high-sensitivity C-reactive protein quantification was carried out by latex-enhanced nephelometry. 9 For lipid profiles, a direct measurement method for the enzymatic determination of cholesterol esters without measuring total cholesterol and free cholesterol was used. 10 Analytical procedures for total cholesterol, low-density lipoprotein and high-density lipoprotein measurements were performed. Nonhigh-density lipoprotein cholesterol was calculated as the difference between total and high-density lipoprotein cholesterol. 10 Finally, insulin and glucose levels were measured.
Ultrasonographic measurement of common CIMT was performed according to the method described by Hodis et al.
11
using an Acuson Sequoia 512 mainframe (Acuson, Siemens Medical Solutions USA, Inc., Mountain View, CA, USA) with a 15L8 MHz linear-array transducer. All ultrasonography scans were performed by one experienced vascular sonographer. The proximal part of the left carotid bulb was identified and the segments of the common carotid artery 1 to 2 cm proximal to the bulb and the proximal segment of the internal carotid artery 1 cm distal to the bulb were scanned. The images were focused on the posterior wall away from the transducer ('far wall'), and a resolution box function was used to magnify the arterial far wall. Scans were digitally stored for subsequent off-line analysis. Three complete and independent cardiac cycles were selected and analyzed for mean, diastolic and systolic CIMT. An image analyst, blinded to patient status (ECMO vs control) measured CIMT from the far wall of the left common carotid arteries by an automated computerized edge detection using a Siemens software package (2002, version 1.0). Finally, the CIMT values were reproducible with a high degree of precision with a median coefficient of variation for repeated measures of 2%. 12 
Statistical analysis
The distribution of continuous variables was tested for normality. For normally distributed variables, equality of the means was tested by the t-test. For all other continuous variables, equality of distribution was tested by the Mann-Whitney U-test. For categorical variables, the distribution or proportions of patients between groups were compared by Fisher's exact test. Analysis of covariance was used to correct the effect of carotid artery size on CIMT. A P<0.05 was considered significant and all hypothesis testing was two-sided. Data are given as mean ± s.d. Statistical analysis was carried out using STATA for Windows (version 8.0, TX, USA).
Results
Thirty-one neonatal venoarterial ECMO survivors were matched to 31 healthy non-ECMO controls based on chronological age and percentage of BMI. As expected, no significant differences were found between ECMO survivors and non-ECMO controls for age (16.2±1.4 vs 16.8±1.8 years), weight (68.5±18.4 vs 69.8 ± 16.6 kg), and percentage of BMI (73.5 ± 29.2 vs 73.6±29.5%). Systolic (109±8.8 vs 113±9.3 mm Hg) and diastolic (50 ± 1.6 vs 54 ± 1.4 mm Hg) blood pressures also did not differ between the groups. Demographic data and laboratory findings are shown in Table 1 . There were 20 female and 11 male patients in each group. Baseline serum insulin, glucose, homocysteine, high-sensitivity C-reactive protein levels and lipid profiles did not differ between the groups.
Relevant clinical characteristics of the ECMO survivors in the neonatal period are described in Table 2 . Fifty-five percent of the late preterm or term gestation ECMO patients were suffering from severe hypoxemic respiratory failure because of meconium aspiration syndrome (55%) whereas the rest had other underlying pathology resulting in hypoxemic respiratory failure including congenital diaphragmatic hernia in 13% of these patients. The majority (>90%) of patients had a 10 French or larger arterial catheter placed for ECMO support. Similarly, >90% of patients had at least a 10 French (or larger) venous catheter inserted for drainage of blood from the right atrium. All patients had their right carotid artery sacrificed without any attempt to reconstruct it.
Mean CIMTs during the different phases of the cardiac cycle are described in Table 3 . Significant differences between ECMO and controls patients were found in the left systolic CIMT (0.39 ± 0.04 vs 0.37±0.04 mm; P ¼ 0.05), left diastolic CIMT (0.42±0.01 vs 0.39 ± 0.01 mm; P ¼ 0.03) and left mean CIMT (0.40 ± 0.01 vs 0.38 ± 0.01 mm; P ¼ 0.04). There were significant differences between the neonatal venoarterial ECMO survivors and the healthy non-ECMO controls in carotid artery diameter in diastole (0.58±0.05 mm vs 0.56±0.05 mm; P<0.003) and systole (0.69 ± 0.05 mm vs 0.64 ± 0.05 mm; P<0.008). There were no differences in demographics, measured laboratory parameters or CIMT measurements between patients with congenital diaphragmatic hernia (n ¼ 4) as compared with patients with other diagnoses. After controlling for the effect of the diameter of the left carotid artery, the difference in left CIMT in systole remained significant (P<0.05) whereas the difference in the diastolic and mean CIMT was no longer statistically significant between the two groups (P>0.05).
Discussion
To our knowledge, this is the first prospective matched control study comparing the left CIMT and biochemical markers for CVD risks in normal non-ECMO controls with neonatal venoarterial ECMO survivors with permanent ligation of the RCCA. Our results indicate that venoarterial ECMO survivors dependent on one carotid artery have a significant increase in left CIMT compared with normal non-ECMO controls when matched for age and percentage of BMI between 12 and 18 years of age. The increased left carotid artery CIMT in neonatal venoarterial ECMO survivors cannot be explained by differences in glucose metabolism, lipid homeostasis or inflammatory marker profiles as there were no differences between the two groups in serum insulin, glucose, homocysteine and high-sensitivity C-reactive protein levels and lipid profiles. Interestingly, the average diameter of the left carotid artery in neonatal venoarterial ECMO survivors was significantly greater in all phases of the cardiac cycle compared with that in age-matched normal non-ECMO controls and percentage of BMI-matched normal non-ECMO controls. This increase in left carotid diameter size may represent a compensatory growth and/or stretch as a consequence of the redistribution of blood flow in the absence of flow through the ligated right carotid artery. After controlling for the size of the carotid artery, we have found that neonatal venoarterial ECMO survivors have a persistent increase in left CIMT during maximal systolic vessel stretch compared with the normal non-ECMO controls. Although after controlling for vessel size, there was no difference in left CIMT in diastole between the two groups, our finding that CIMT is increased during systolic vessel stretch suggests that the changes independent of compensatory vessel In adults, increases in CIMT are associated with an increased risk for stroke and coronary vascular disease. 13, 14 Importantly, the rate of CIMT changes over time is associated with increased risks for coronary events. 11 In children, abnormal lipid metabolism, obesity, hypertension and smoking are also significantly associated with an increased risk in CVD Increased childhood CIMT has been reported in children diagnosed with hypertension, end-stage renal disease, juvenile-onset systemic lupus erythematous and in patients with metabolic derangements of glucose, homocysteine and lipid metabolism. However, unlike in adults, the association between childhood CIMT and cardiovascular risk events has not been characterized. [15] [16] [17] [18] A relevant naturally occurring and exceedingly rare phenomenon is the congenital absence or hypoplasia of one of the carotid arteries identified in 0.13% of 5100 adults in a recent study using magnetic resonance imaging (MRI). 19 However, associated cardiovascular changes, including changes in CIMT, in patients with naturally occurring absence of one carotid artery have not been reported in the literature.
Our study has significant limitations. The relatively small sample size and the resolution of the presently available ultrosonographic technology have already been mentioned. Most importantly, we have no information on the natural course of the changes in CIMT described in this study and whether these changes will translate into cardiovascular pathology with an impact on cerebrovascular health during adulthood. In addition, we need more information on the pathogenesis of intimal thickening in patients with a single carotid artery. Therefore, the data presented in this study should not affect the decision-making process when a neonate with hypoxic respiratory failure unresponsive to medical management is being considered to undergo cannulation to receive venoarterial ECMO support.
In summary, our study is the first one to report measurements of CIMT in children with one carotid artery and the finding of an increase in the carotid artery CIMT in this patient population is intriguing. The clinical significance of the increase in CIMT in our study is unknown. Therefore, these findings need to be confirmed and the patients followed into adulthood with a focus on clinically relevant CVD risks assessment and avoidance. The only recommendation we can make at present is that ECMO centers may want to consider incorporating assessment of carotid artery CIMT measurements in their follow-up protocol to collect more data on cardiovascular evaluation of neonatal venoarterial ECMO survivors and ensure that these patients are being appropriately followed once reaching adulthood.
Disclosure
None.
